PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Europe

UK First as London Hospital Takes Part in New International Clinical Trial for Brain Cancer

Consultant oncologists and neurologists are being asked to put patients forward to participate in a landmark international clinical trial of a new radiation treatmen...
Continue Reading →
Europe

Despite late-stage win, investors not sold on Global Blood sickle cell drug

Global Blood Therapeutics has in hand positive data from a late-stage study of its sickle cell disease drug, which could be a "promising advancement" in the way t...
Continue Reading →
news

Bowel cancer: 3-drug combo may offer alternative to chemo

Chemotherapy treatment for people who have advanced bowel cancer and a particular genetic mutation is commonly ineffective. A combination of three different drugs co...
Continue Reading →
news

New drug relieves acute migraine in clinical trial

People who experience acute migraine may soon find relief in a new treatment. The results of a clinical trial of a novel drug revealed that it can eliminate head pa...
Continue Reading →
Europe

Amgen’s KRAS success has other drugmakers eager to follow

After decades of frustrated research efforts, enthusiasm is rising for early-stage clinical work to develop drugs that target a genetic mutation known as KRAS, an...
Continue Reading →
Europe

Healthy lifestyle may offset genetic risk of dementia

Living a healthy lifestyle may help offset a person's genetic risk of dementia, according to new research. The study was led by the University of Exeter - simultaneo...
Continue Reading →
Europe

Roche touts torrent of Hemlibra data amid hemophilia gene therapy deal delays

Roche showed off additional efficacy and safety data for fast-growing hemophilia A drug Hemlibra. (Roche) Roche’s Hemlibra has been growing at eye-catching spee...
Continue Reading →
Europe

Alnylam’s Onpattro back in the game against Ionis, thanks to NICE U-turn

England's National Institute for Health and Care Excellence has decided to back Alnylam's gene-silencing therapy Onpattro, following a thumbs-up to Ionis' rival med...
Continue Reading →
news

Score! ‘Good Pharma’ ranking finds uptick in new drug data sharing and clinical trial transparency

Pharma companies' data sharing around new drug clinical data is on the rise, offering a boost to patient-centricity trustworthiness, a new study finds. (Pixabay) ...
Continue Reading →
Europe

New GSK data raises threat to Gilead’s star HIV drug

Credit: GSK via Flickr ViiV Healthcare, an HIV drugmaker majority owned by GlaxoSmithKline, released clinical data Wednesday showing its two-drug therapy was abl...
Continue Reading →
Quotient